E53G (p.Glu53Gly) variant of BCL10 (B-cell lymphoma/leukemia 10)
E53G (p.Glu53Gly) in BCL10 (B-cell lymphoma/leukemia 10) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
E53G (p.Glu53Gly) variant details
- p.Glu53Gly
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.